Global Neurostimulation Devices Market Key Information By Top Key Player Medtronic, Cyberonics, Boston Scientific Corporation, Abbott (St. Jude Medical)

Neurostimulation Devices Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Japan, China, India, Mexico and etc,), Application Development status, Competitive Market Share & Forecast, 2017 – 2024.

Owing to the exponential rise in the incidences of neurological diseases among the geriatric population, neurostimulation devices market has attained significant popularity over the past few years. The rising demand for minimally invasive technologies across developed nations for treating neurological disorders has compelled neurostimulation devices industry players to come up with innovative products. Advantages offered by minimally invasive surgeries (MIS) including smaller incisions, minimized risk of complications, lower operative pain, and reduced hospital stays have been among the prominent factors to have boosted the growth prospects of neurostimulation devices market.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/467711

Citing an instance to highlight the dire need of developing such pathbreaking technologies, the London headquartered medical devices manufacturer LivaNova has recently inked a USD 225 million deal to acquire ImThera Medical. With the latest takeover, LivaNova reportedly intends to add aura6000, a neurostimulator implant that has been developed to treat obstructive sleep apnea, to its existing product portfolio. Given the fact that aura6000 stimulates the tongue through the hypoglossal nerve during sleep, the implant has garnered a rather commendable appreciation across the neurostimulation devices industry.

How innovative product launches have been reshaping the neurostimulation devices industry landscape
With the rapid influx of globally-renowned medical device manufacturers in the fast-evolving neurostimulation devices market, the clinal proof of effectiveness of the products has gained immense significance. Moreover, the current competitive scenario of this business space has necessitated leading market participants to launch unique products and secure regulatory approval in lesser timespan. Following is a brief summary of how neurostimulation devices industry players have been proactive in releasing cutting-edge products in the recent past:
Regarded as one of the foremost neurostimulation devices market giant, Boston Scientific Corporation has recently announced to have received the U.S. FDA’s approval for its Vercise™ Deep Brain Stimulation (DBS) System.
The system would apparently be deployed to treat Parkinson’s disease, a degenerative condition that affects more than 10 million people worldwide and approximately one million in the USA. Powered by a device called an implantable pulse generator, DBS works by stimulating specific regions of the brain via implant leads. The approval marks an important step for patients who will now have the choice to be treated with more adaptable neurostimulation device.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/467711

The Illinois based healthcare multinational, Abbott has recently declared to have launched its Proclaim™ DRG Neurostimulation System in Europe. The revolutionary system has been developed to treat chronic neuropathic pain by dorsal root ganglion (DRG) stimulation. The Proclaim DRG Neurostimulation System provides a more innate therapy experience, given that it has been equipped with iOS™ software and Bluetooth® wireless technology. The system is said to enhance the experience of how patients interact with their device compared to existing systems with outdated controllers that are problematic to operate. Apparently, the launch of Proclaim DRG Neurostimulation System would undoubtedly impel the Europe neurostimulation devices industry growth in the ensuing years.

Touted as the smallest implantable spinal cord stimulator across the neurostimulation devices market, Medtronic’s Intellis system has reportedly secured regulatory approval in Europe. The system can be utilized to treat either peripheral nerve or spinal cord neurostimulation, relieving chronic pain. The Intellis implant offers both low-dose and high-dose therapy, depending on the needs of the patients. Furthermore, it also helps physicians to improve how the therapy targets pain by tracking patient activity.
With the advancements in technological innovations coupled with soaring elderly patient base across the globe, the neurostimulation devices industry is bound to accrue substantial remuneration over the estimated timeframe. The overall neurostimulation devices market is forecast to surpass a total revenue portfolio of USD 16 billion by 2024.

Major Points in Table of Contents

Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary

Chapter 2. Executive Summary
2.1. Neurostimulation devices industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends

Chapter 3. Neurostimulation Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing demand for minimally invasive technologies in the developed countries
3.3.1.2. Rising prevalence of neurological disorders in U.S and Europe
3.3.1.3. Growing adoption of innovative and technologically advanced products
3.3.1.4. Increasing number of elderly patients with neurological disorders in the U.S and European countries

Related Reports: -
North America Implantable Neurostimulation Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2022
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
https://www.marketstudyreport.com/reports/north-america-implantable-neurostimulation-devices-market-by-manufacturers-countries-type-and-application-forecast-to-2022/?utm_source=RR-SP

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.